http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111053755-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111053755-B
titleOfInvention Preparation method of high-permeability cefixime capsule preparation
abstract The invention relates to a preparation method of cefixime preparation for improving bioavailability, belonging to the technical field of medicines. The invention co-crystallizes cefixime and at least one transmembrane reinforcing agent to prepare a thermally stable co-crystal, the co-crystal is mixed with proper auxiliary materials and filled to prepare the capsule preparation, and the co-crystal can improve the transmembrane operation capability of cefixime in the body, thereby increasing the permeability in the body and achieving the effect of improving the bioavailability in the body.
priorityDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016144590-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016205172-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013059664-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5742673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457797993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425823269

Total number of triples: 45.